DE1793794A1 - Pharmazeutische zusammensetzungen - Google Patents
Pharmazeutische zusammensetzungenInfo
- Publication number
- DE1793794A1 DE1793794A1 DE19661793794 DE1793794A DE1793794A1 DE 1793794 A1 DE1793794 A1 DE 1793794A1 DE 19661793794 DE19661793794 DE 19661793794 DE 1793794 A DE1793794 A DE 1793794A DE 1793794 A1 DE1793794 A1 DE 1793794A1
- Authority
- DE
- Germany
- Prior art keywords
- compositions according
- group
- denotes
- steroid
- unit contains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 239000000203 mixture Substances 0.000 claims 9
- 150000003431 steroids Chemical class 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000002934 diuretic Substances 0.000 claims 1
- 230000001882 diuretic effect Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000001804 emulsifying effect Effects 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 230000001076 estrogenic effect Effects 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- -1 steroid hemiacetal Chemical class 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51469165A | 1965-12-17 | 1965-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1793794A1 true DE1793794A1 (de) | 1975-07-31 |
Family
ID=24048303
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661793794 Pending DE1793794A1 (de) | 1965-12-17 | 1966-12-17 | Pharmazeutische zusammensetzungen |
| DE19661593348 Expired DE1593348C3 (de) | 1965-12-17 | 1966-12-17 | Verfahren zur Herstellung von 19-Fluorsteroidepoxyden und 19-Fluor-11,19epoxysteroide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661593348 Expired DE1593348C3 (de) | 1965-12-17 | 1966-12-17 | Verfahren zur Herstellung von 19-Fluorsteroidepoxyden und 19-Fluor-11,19epoxysteroide |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE691320A (enExample) |
| CH (1) | CH587290A5 (enExample) |
| DE (2) | DE1793794A1 (enExample) |
| DK (1) | DK123407B (enExample) |
| FR (2) | FR1511151A (enExample) |
| GB (1) | GB1177648A (enExample) |
| IL (1) | IL27072A (enExample) |
| NL (1) | NL6617739A (enExample) |
| SE (1) | SE348190B (enExample) |
-
1966
- 1966-12-13 GB GB5587466A patent/GB1177648A/en not_active Expired
- 1966-12-16 IL IL2707266A patent/IL27072A/en unknown
- 1966-12-16 BE BE691320D patent/BE691320A/xx unknown
- 1966-12-16 DK DK653366A patent/DK123407B/da unknown
- 1966-12-16 SE SE1727966A patent/SE348190B/xx unknown
- 1966-12-16 FR FR87807A patent/FR1511151A/fr not_active Expired
- 1966-12-16 NL NL6617739A patent/NL6617739A/xx unknown
- 1966-12-17 DE DE19661793794 patent/DE1793794A1/de active Pending
- 1966-12-17 DE DE19661593348 patent/DE1593348C3/de not_active Expired
- 1966-12-19 CH CH1812266A patent/CH587290A5/de not_active IP Right Cessation
-
1967
- 1967-03-16 FR FR99003A patent/FR6920M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1593348C3 (de) | 1975-03-06 |
| CH587290A5 (en) | 1977-04-29 |
| SE348190B (enExample) | 1972-08-28 |
| NL6617739A (enExample) | 1967-06-19 |
| DE1593348B2 (de) | 1974-07-18 |
| DE1593348A1 (de) | 1970-07-30 |
| DK123407B (da) | 1972-06-19 |
| IL27072A (en) | 1972-07-26 |
| BE691320A (enExample) | 1967-06-16 |
| GB1177648A (en) | 1970-01-14 |
| FR6920M (enExample) | 1969-05-05 |
| FR1511151A (fr) | 1968-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69118493T2 (de) | Orales Kontrazeptin mit niedrigem Östrogen-Enthalt | |
| DE2661011C2 (de) | 17ß-Ester von Östradiol | |
| DE69403082T2 (de) | Wässrige alkoholische kosmetische mikroemulsionen | |
| DE2621214C3 (de) | Verwendung von Stabilisatoren in Arzneimitteln mit Fumarsäuremonoäthylester und desen Mineralsalzen | |
| DE312867T1 (de) | Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten. | |
| DE2447699C2 (de) | Steroidhaltige topische Salbengrundlage | |
| DE4330234A1 (de) | Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten | |
| DE2704081A1 (de) | Mittel mit einem gehalt an siliciumderivaten | |
| DE3120742A1 (de) | Antiperspirans, das als antiperspirativen wirkstoff ein aluminiumchlorid und ein aluminium-zirkonium-hydroxychlorid enthaelt, sowie das verfahren zu dessen anwendung | |
| DE2645307C2 (enExample) | ||
| DE3238984C2 (enExample) | ||
| EP0320437A3 (de) | 17-Methylen- und 17-Ethyliden-Estratriene mit östrogener Wirkung | |
| DE2434849A1 (de) | Herzstaerkende dosierungseinheit mit einer ein praeparat enthaltenden kapsel | |
| STRAUSS et al. | Effect of Enovid on sebum production in females: A preliminary report | |
| DE975623C (de) | Wirkstoffe, z. B. Desinfektionsmittel, und hoehermolekulare Fettalkohole sowie Fettalkoholsulfate enthaltende fluessige Mund- und Zahnpflegemittel | |
| DE1517291A1 (de) | Verbesserung der Raucheigenschaften von Tabaken | |
| DE2539824A1 (de) | Pharmazeutische zubereitung | |
| DE1792338B1 (de) | Lichtschutzmittel | |
| US2381830A (en) | Medicinal preparation | |
| DE3240044A1 (de) | Verwendung von 17(alpha)-acyloxy-6-methylpregna-4,6-dien-3,20-dionen zur bekaempfung von brustkrebs | |
| DE1246168B (de) | Stiftmassen fuer pharmazeutische und kosmetische Praeparate | |
| DE2608123B2 (de) | Antischweißmittel in Aerosolform | |
| DE1667931C (de) | Arzneimittel gegen Koronarinsuffizienz | |
| DE3511588A1 (de) | Waessrige kristallsuspension von steroidglykoestern | |
| DE2059338A1 (de) | Arzneimittel auf der Basis von Cyproteron und dessen Estern sowie Methode zur Behandlung der Pubertas praecox |